Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Keryx Biopharmaceuticals, Inc. (NQ: KERX)
8.240 USD  +0.580 (+7.57%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Keryx Biopharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
38 39 Next >
Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) and Cytokinetics, Incorporated (NASDAQ:CYTK) Added to Equity Profile Report's NASDAQ Gainers Watch List.
Today 17:21 EDT
Wilmington, DE -- (SBWIRE) -- 06/19/2013 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) and Cytokinetics, Incorporated... Read More
from SBWire - Latest Press Releases
Mid-Afternoon Market Update: Markets Fall Following FOMC Statement; Adobe Remains on the Rise
Today 15:41 EDT
Toward the end of trading Wednesday, the Dow traded down 0.75 percent to 15,202.86 while the NASDAQ declined 0.57 percent to 3,462.11. The S&P also fell, dropping 0.72 percent to 1,639.51. Top Headline... Read More
category TTEK , Earnings , BBRY , and 17 more.
from Latest Articles from Benzinga.com
Mid-Day Market Update: La-Z-Boy Drops On Q4 Results, Nektar Gains
Today 12:32 EDT
Midway through trading Wednesday, the Dow traded down 0.05 percent to 15,309.86 while the NASDAQ declined 0.09 percent to 3,479.11. The S&P also fell, dropping 0.08 percent to 1,650.51. Top Headline... Read More
category TTEK , Earnings , NKTR , and 17 more.
from Latest Articles from Benzinga.com
Afternoon Market Gainers
Today 12:29 EDT
Bluebird Bio (NASDAQ: BLUE ) traded up 49.55 percent to $25.41. Wednesday's IPO for the company was initially priced at $17. Nektar Therapeutics (NASDAQ: NKTR ) rose 9.99 percent to $10.79 after... Read More
category NKTR , Benzinga , Movers , and 5 more.
from Latest Articles from Benzinga.com
Keryx Biopharmaceuticals Rising on Above-Average Volume, Consistent With Trend (KERX)
Today 10:58 EDT
from Comtex SmarTrend® News Briefs
Mid-Morning Market Update: Markets Edge Lower, FedEx Posts Upbeat Profit
Today 10:32 EDT
Following the market opening Wednesday, the Dow traded down 0.17 percent to 15,292.21 while the NASDAQ declined 0.06 percent to 3,480.22. The S&P also fell, dropping 0.18 percent to 1,648.87. Top... Read More
category TTEK , Earnings , LZB , and 17 more.
from Latest Articles from Benzinga.com
Notable Analyst Rating Changes 06/19: (CX) (ADBE) (LINE) Upgraded; (CLF) (S) (BBRY) Downgraded
Today 10:30 EDT
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8431101 for the full story. Read More
from StreetInsider.com News Articles
StreetInsider.com Pre-Open Movers 6/19: (PLX) (CYTK) (ADBE) Higher; (OSH) (VNDA) (TTEK) Lower (more...)
Today 9:30 EDT
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8430817 for the full story. Read More
from StreetInsider.com News Articles
JPMorgan Starts Keryx Biopharmaceuticals (KERX) at Overweight
Today 8:20 EDT
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8430256 for the full story. Read More
from StreetInsider.com News Articles
Keryx Biopharmaceuticals - Market Digest
Today 3:00 EDT
NEW YORK (AVAFIN) -- Institutional trading of Keryx Biopharmaceuticals shares yielded a bought/sold volume ... Read More
from AVAFIN
Litigation Settlements, Data Compliance Reviews, and Clinical Trials Pave Way for Solid Footing in Healthcare - Research Report on Pfizer, Merck, Bristol-Myers Squibb, Keryx and Pacira Pharmaceuticals
June 17, 2013
Editor Note: For more information about this release, please scroll to bottom Read More
from PR Newswire
GSK, AZN, KERX, and RPTP Early Briefing and Review
June 07, 2013
from ACCESSWIRE
Keryx (KERX) Will Present Updated Zerenex Phase 3 Data
June 03, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8384401 for the full story. Read More
from StreetInsider.com News Articles
Keryx Biopharmaceuticals, Inc. Announces Zerenex™ Phase 3 Data Presented at the 2013 World Congress of Nephrology
June 03, 2013
from PR Newswire
Commit To Buy Keryx Biopharmaceuticals At $5, Earn 26%
May 31, 2013
Investors considering a purchase of Keryx Biopharmaceuticals Inc. (KERX) shares, but tentative about paying the going market price of $8.14/share, might benefit from considering selling puts among the... Read More
category Stocks
from Market News Video
Commit To Buy Keryx Biopharmaceuticals At $5, Earn 26%
May 31, 2013
Investors considering a purchase of Keryx Biopharmaceuticals Inc. (KERX) shares, but tentative about paying the going market price of $8.14/share, might benefit from considering selling puts among the... Read More
category Dividends
from Dividend Channel
Keryx Biopharmaceuticals Earnings Hindsight: Up 0.6% in Last 13 Days (KERX)
May 20, 2013
from Comtex SmarTrend® News Briefs
UPDATE: Oppenheimer Raises PT on Keryx Biopharmaceuticals Following Management Meetings
May 17, 2013
In a report published Friday, Oppenheimer analyst Boris Peaker reiterated an Outperform rating on Keryx Biopharmaceuticals (NASDAQ: KERX ), and slightly raised the price target from $11.00 to $12.00.... Read More
category Oppenheimer , KERX , Benzinga , and 3 more.
from Latest Articles from Benzinga.com
NASDAQ Active Stock Watch List: Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Life Technologies Corporation (NASDAQ:LIFE), and Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Added to Growing Stock Report'
May 16, 2013
New York, NY -- (SBWIRE) -- 05/16/2013 -- Growing Stock Report expands its NASDAQ Active Stock Weekly Watch List adding Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Life Technologies Corporation... Read More
from SBWire - Latest Press Releases
Losers Review (Gold Fields Limited, L&L Energy, Keryx Biopharmaceuticals, Allied Nevada Gold Corp)
May 15, 2013
Austin, TX -- (SBWIRE) -- 05/15/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues... Read More
from SBWire - Latest Press Releases
NASDAQ Active Stock Watch List: Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Unilife Corporation (NASDAQ:UNIS), and Mylan, Inc. (NASDAQ:MYL) Added to Equity Profile Report's NASDAQ Active Stock Watch
May 14, 2013
Wilmington, DE -- (SBWIRE) -- 05/14/2013 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Unilife Corporation... Read More
from SBWire - Latest Press Releases
KERX, ARIA, PDLI added to BioStock Watch List at GSR
May 14, 2013
from ACCESSWIRE
Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), PDL BioPharma, Inc. (NASDAQ:PDLI), and ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Added to Growing Stock Report's
May 14, 2013
New York, NY -- (SBWIRE) -- 05/14/2013 -- Growing Stock Report expands its Biotech Gainers Weekly Watch List adding Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Ariad Pharmaceuticals Inc.... Read More
from SBWire - Latest Press Releases
Stocks to Watch for May 14, 2013
May 13, 2013
category KERX , ZNGA , TSLA , and 3 more.
from AC Investor Blog
Technical Stock Breakout Watch: Keryx Biopharmaceuticals (KERX)
May 13, 2013
Bridgewater, MA -- (SBWIRE) -- 05/13/2013 -- The online StockConsultant latest screen has found a biotech company that provides drugs for the treatment of cancer and renal diseases Keryx... Read More
from SBWire - Latest Press Releases
Trading Alert for Keryx Biopharmaceuticals
May 13, 2013
NEW YORK (AVAFIN) -- Trading of Keryx Biopharmaceuticals options resulted in establishing a new ... Read More
from AVAFIN
Keryx Biopharmaceuticals, Inc. (KERX) Posts Mixed Q1 Results
May 07, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8314080 for the full story. Read More
from StreetInsider.com News Articles
Keryx Biopharmaceuticals, Inc. Announces First Quarter 2013 Financial Results
May 07, 2013
Keryx to Host Investor Conference Call on Wednesday, May 8, 2013 at 8:30am EDT Read More
from PR Newswire
Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2013 Financial Results
May 06, 2013
Investor Conference Call to be held Wednesday, May 8, 2013 at 8:30am EDT Read More
from PR Newswire
Grab KERX 7.9% Cheaper Than Its Secondary?
May 02, 2013
Looking back to 92 days ago, Keryx Biopharmaceuticals Inc. (KERX) priced a 8,234,000 share secondary stock offering at $8.49 per share. Read More
category Stocks
from Market News Video
< Previous 1 2 3 4 5 6 7 8 9
...
38 39 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here